Literature DB >> 22676301

Fundamentals of population pharmacokinetic modelling: modelling and software.

Tony K L Kiang1, Catherine M T Sherwin, Michael G Spigarelli, Mary H H Ensom.   

Abstract

Population pharmacokinetic modelling is widely used within the field of clinical pharmacology as it helps to define the sources and correlates of pharmacokinetic variability in target patient populations and their impact upon drug disposition. This review focuses on the fundamentals of population pharmacokinetic modelling and provides an overview of the commonly available software programs that perform these functions. This review attempts to define the common, fundamental aspects of population pharmacokinetic modelling through a discussion of the literature describing the techniques and placing them in the appropriate context. An overview of the most commonly available software programs is also provided. Population pharmacokinetic modelling is a powerful approach where sources and correlates of pharmacokinetic variability can be identified in a target patient population receiving a pharmacological agent. There is a need to further standardize and establish the best approaches in modelling so that any model created can be systematically evaluated and the results relied upon. Various nonlinear mixed-effects modelling methods, packaged in a variety of software programs, are available today. When selecting population pharmacokinetic software programs, the consumer needs to consider several factors, including usability (e.g. user interface, native platform, price, input and output specificity, as well as intuitiveness), content (e.g. algorithms and data output) and support (e.g. technical and clinical).

Entities:  

Mesh:

Year:  2012        PMID: 22676301     DOI: 10.2165/11634080-000000000-00000

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  12 in total

1.  Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery.

Authors:  Sara L Van Driest; Matthew D Marshall; Brian Hachey; Cole Beck; Kim Crum; Jill Owen; Andrew H Smith; Prince J Kannankeril; Alison Woodworth; Richard M Caprioli; Leena Choi
Journal:  Br J Clin Pharmacol       Date:  2016-04-15       Impact factor: 4.335

2.  Population Pharmacokinetics of Mycophenolic Acid Co-Administered with Tacrolimus in Corticosteroid-Free Adult Kidney Transplant Patients.

Authors:  Yan Rong; Patrick Mayo; Mary H H Ensom; Tony K L Kiang
Journal:  Clin Pharmacokinet       Date:  2019-11       Impact factor: 6.447

3.  Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation.

Authors:  S F Marshall; R Burghaus; V Cosson; S Y A Cheung; M Chenel; O DellaPasqua; N Frey; B Hamrén; L Harnisch; F Ivanow; T Kerbusch; J Lippert; P A Milligan; S Rohou; A Staab; J L Steimer; C Tornøe; S A G Visser
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-03-14

Review 4.  Voriconazole: A Review of Population Pharmacokinetic Analyses.

Authors:  Changcheng Shi; Yubo Xiao; Yong Mao; Jing Wu; Nengming Lin
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

Review 5.  Prediction of drug disposition on the basis of its chemical structure.

Authors:  David Stepensky
Journal:  Clin Pharmacokinet       Date:  2013-06       Impact factor: 6.447

Review 6.  Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.

Authors:  Thomas E Yankeelov; Gary An; Oliver Saut; E Georg Luebeck; Aleksander S Popel; Benjamin Ribba; Paolo Vicini; Xiaobo Zhou; Jared A Weis; Kaiming Ye; Guy M Genin
Journal:  Ann Biomed Eng       Date:  2016-07-06       Impact factor: 3.934

7.  Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-04-17

8.  Using sensitivity equations for computing gradients of the FOCE and FOCEI approximations to the population likelihood.

Authors:  Joachim Almquist; Jacob Leander; Mats Jirstrand
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-03-24       Impact factor: 2.745

Review 9.  Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.

Authors:  Daniel Gonzalez; Gauri G Rao; Stacy C Bailey; Kim L R Brouwer; Yanguang Cao; Daniel J Crona; Angela D M Kashuba; Craig R Lee; Kathryn Morbitzer; J Herbert Patterson; Tim Wiltshire; Jon Easter; Scott W Savage; J Robert Powell
Journal:  Clin Transl Sci       Date:  2017-08-10       Impact factor: 4.689

10.  Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate.

Authors:  Leo Turner; Lam P Ly; Reena Desai; Gurmeet K S Singh; Timothy D Handelsman; Sasha Savkovic; Carolyn Fennell; Veena Jayadev; Ann Conway; David J Handelsman
Journal:  J Endocr Soc       Date:  2019-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.